Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation

This publication has 22 references indexed in Scilit:

• LONG-TERM ORAL GANCICLOVIR PROPHYLAXIS FOR PREVENTION OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN CYTOMEGALOVIRUS HIGH-RISK RENAL TRANSPLANT RECIPIENTS
  Transplantation, 2000
• Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis
  Transplant Infectious Disease, 2000
• Prophylaxis of cytomegalovirus infection in renal transplantation.
  Nephrology Dialysis Transplantation, 1998
• A RANDOMIZED PROSPECTIVE CONTROLLED TRIAL OF ORAL ACYCLOVIR VERSUS ORAL GANCICLOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK KIDNEY TRANSPLANT RECIPIENTS1
  Transplantation, 1998
• PROPHYLACTIC ORAL GANCICLOVIR COMPARED WITH DEFERRED THERAPY FOR CONTROL OF CYTOMEGALOVIRUS IN RENAL TRANSPLANT RECIPIENTS1,2,???
  Transplantation, 1997
• Studies Evaluating High-Dose Acyclovir, Intravenous Immune Globulin, and Cytomegalovirus Hyperimmunoglobulin for Prophylaxis against Cytomegalovirus in Kidney Transplant Recipients
  Annals of Pharmacotherapy, 1996
• Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Cytomegalovirus Antibody-Positive Renal Transplant Recipients
  Annals of Internal Medicine, 1995
• Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants
  The American Journal of Medicine, 1993
• A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts
  New England Journal of Medicine, 1989
• Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant Recipients
  New England Journal of Medicine, 1987